Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

News in brief

ChemCon approved to make semisolids


Ingredient supplier ChemCon GmbH has been cleared to make semi-solid dosage forms by German regulators.

The firm – which supplies active pharmaceutical ingredients and fine chemicals from its manufacturing facility in Freiburg – said that the approval will allow it to access new customers and provide services at all stages of the drug development process.

ChemCon cited its recent production of an antiviral API based upon a tellurium complex and placebo gel forms for an unnamed customer for a Phase II clinical trial as an example of the type of work it is now able to do now the approval is in place.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing